| Nome |
# |
|
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management, file 3c9d3ab2-ba23-4638-ba67-48af4d2a808c
|
186
|
|
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence, file dd9e0c65-6bb6-1e9c-e053-3a05fe0a45ef
|
66
|
|
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading, file dd9e0c66-c59f-1e9c-e053-3a05fe0a45ef
|
63
|
|
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association, file dd9e0c65-7677-1e9c-e053-3a05fe0a45ef
|
56
|
|
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease, file dd9e0c63-8693-1e9c-e053-3a05fe0a45ef
|
55
|
|
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report, file dd9e0c63-dc46-1e9c-e053-3a05fe0a45ef
|
49
|
|
Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces, file 2e6fda2c-0814-4d68-ad2d-0f6a88967a46
|
44
|
|
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis, file dd9e0c62-eb35-1e9c-e053-3a05fe0a45ef
|
44
|
|
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study, file dd9e0c6a-9530-1e9c-e053-3a05fe0a45ef
|
41
|
|
null, file dd9e0c6a-ab9b-1e9c-e053-3a05fe0a45ef
|
39
|
|
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort, file dd9e0c65-69a9-1e9c-e053-3a05fe0a45ef
|
26
|
|
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases, file dd9e0c63-8d9c-1e9c-e053-3a05fe0a45ef
|
24
|
|
CD20: A target antigen for immunotherapy of autoimmune diseases, file dd9e0c63-8d9e-1e9c-e053-3a05fe0a45ef
|
15
|
|
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic, file dd9e0c64-9a95-1e9c-e053-3a05fe0a45ef
|
15
|
|
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice, file dd9e0c62-5cef-1e9c-e053-3a05fe0a45ef
|
10
|
|
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes, file dd9e0c63-8989-1e9c-e053-3a05fe0a45ef
|
9
|
|
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma, file dd9e0c63-dbdf-1e9c-e053-3a05fe0a45ef
|
9
|
|
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype, file dd9e0c63-dbe6-1e9c-e053-3a05fe0a45ef
|
7
|
|
null, file dd9e0c66-4fd0-1e9c-e053-3a05fe0a45ef
|
7
|
|
Serological methods to detect anti-idiotypic antibodies, file dd9e0c62-7a89-1e9c-e053-3a05fe0a45ef
|
6
|
|
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir, file b10672fa-ed9a-4a45-8bc7-725f8b555770
|
5
|
|
Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort, file dd9e0c66-c5a2-1e9c-e053-3a05fe0a45ef
|
5
|
|
null, file dd9e0c6b-749e-1e9c-e053-3a05fe0a45ef
|
5
|
|
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients, file cd1aef79-c524-40a8-a6cb-1563ee9d01b9
|
4
|
|
null, file dd9e0c65-69a7-1e9c-e053-3a05fe0a45ef
|
4
|
|
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment, file dd9e0c67-d40f-1e9c-e053-3a05fe0a45ef
|
4
|
|
Vasculitides: Proposal for an integrated nomenclature, file dd9e0c62-e554-1e9c-e053-3a05fe0a45ef
|
3
|
|
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin, file dd9e0c62-e7b6-1e9c-e053-3a05fe0a45ef
|
3
|
|
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy, file dd9e0c63-8988-1e9c-e053-3a05fe0a45ef
|
3
|
|
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?, file dd9e0c67-7e91-1e9c-e053-3a05fe0a45ef
|
3
|
|
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort, file dd9e0c68-a634-1e9c-e053-3a05fe0a45ef
|
3
|
|
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management, file dd9e0c69-5f46-1e9c-e053-3a05fe0a45ef
|
3
|
|
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders., file dd9e0c64-ed2b-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c66-bfdc-1e9c-e053-3a05fe0a45ef
|
2
|
|
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement, file dd9e0c6a-dbde-1e9c-e053-3a05fe0a45ef
|
2
|
|
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension, file dd9e0c6a-feea-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c6b-2417-1e9c-e053-3a05fe0a45ef
|
2
|
|
Peptides highly specific to the variable region of TNF-ALFA-specific references licensed (RL) monoclonal antibodies (MAB), as potential tool to effectively assess similarity between biosimilars and the correspondig RL MAB, file dd9e0c6b-3303-1e9c-e053-3a05fe0a45ef
|
2
|
|
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis, file 0c592f01-2330-42ce-aca2-cadf85cfc23d
|
1
|
|
Systemic sclerosis and primary biliary cholangitis share an antibody population with
identical specificity, file 16e3abf0-4a3c-4692-86f4-20354627ac0a
|
1
|
|
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study, file 63787ffe-56a4-409a-9be5-14ac943e1938
|
1
|
|
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis, file 6d6fb51a-2d81-4e20-85d8-ecdd75ee1aa2
|
1
|
|
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide, file 78c856e7-4b0f-4c2e-87b1-6768ff8993c4
|
1
|
|
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort, file 8ed283f4-a37c-4317-b214-b72374f6169c
|
1
|
|
Human immunoglobulins in therapy. Rational basis and clinical applications, file 9443f081-b08a-487e-971a-202dc03e0a98
|
1
|
|
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry., file b0508656-92d6-4a9d-933b-622227eb2003
|
1
|
|
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2, file dd9e0c62-5c16-1e9c-e053-3a05fe0a45ef
|
1
|
|
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities, file dd9e0c62-619c-1e9c-e053-3a05fe0a45ef
|
1
|
|
Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report, file dd9e0c62-61ba-1e9c-e053-3a05fe0a45ef
|
1
|
|
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects, file dd9e0c62-7a8a-1e9c-e053-3a05fe0a45ef
|
1
|
|
Soluble CD4 and commercial immunoglobulins, file dd9e0c62-cf8d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature, file dd9e0c62-f653-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c62-fa12-1e9c-e053-3a05fe0a45ef
|
1
|
|
L’ospite immunocompromesso: un complesso sindromico in espansione. Quadri clinici, aspetti immunologici e prospettive terapeutiche, file dd9e0c63-60e6-1e9c-e053-3a05fe0a45ef
|
1
|
|
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases, file dd9e0c63-8e00-1e9c-e053-3a05fe0a45ef
|
1
|
|
Dosaggio della catena pesante degli antigeni di istocompatibilità di classe I (HLA-I) nel siero di pazienti con mieloma multiplo, file dd9e0c64-ff72-1e9c-e053-3a05fe0a45ef
|
1
|
|
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients, file dd9e0c68-299c-1e9c-e053-3a05fe0a45ef
|
1
|
|
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?, file dd9e0c6a-a9e9-1e9c-e053-3a05fe0a45ef
|
1
|
|
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification, file dd9e0c6a-c1f9-1e9c-e053-3a05fe0a45ef
|
1
|
|
Immunogenicity of two idiotypes with a different immunoglobulin-chain distribution expressed on the same anti-CD4 Mab, file dd9e0c6a-efbb-1e9c-e053-3a05fe0a45ef
|
1
|
|
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study, file dd9e0c6b-8b95-1e9c-e053-3a05fe0a45ef
|
1
|
|
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study, file dd9e0c6b-9f1a-1e9c-e053-3a05fe0a45ef
|
1
|
|
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis, file f1b11913-d165-4dab-85e5-8339e95d9e45
|
1
|
| Totale |
853 |